3 activation pathway. Br J Pharmacol 2010, 161:54154. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, Sethi G, Aggarwal BB, Liu M: Thymoquinone inhibits tumor angiogenesis and tumor growth by means of suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008, 7:1789796. Das S, Dey KK, Dey G, Pal I, Majumder A, MaitiChoudhury S, Kundu SC, Mandal M: Antineoplastic and apoptotic potential of conventional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One particular 2012, 7:e46641. Gali-Muhtasib H, Ocker M, Kuester D, Krueger S, El-Hajj Z, Diestel A, Evert M, El-Najjar N, Peters B, Jurjus A, et al: Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. J Cell Mol Med 2008, 12:33042. Gali-Muhtasib H, Diab-Assaf M, Boltze C, Al-Hmaira J, Hartig R, Roessner A, Schneider-Stock R: Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells by means of a p53dependent mechanism. Int J Oncol 2004, 25:85766. Dang CV: MYC around the path to cancer.Valsartan Cell 2012, 149:225. Klaus A, Birchmeier W: Wnt signalling and its effect on improvement and cancer. Nat Rev Cancer 2008, 8:38798.Lang et al. Molecular Cancer 2013, 12:41 http://www.molecular-cancer/content/12/1/Page 13 of24. da Costa LT, He TC, Yu J, Sparks AB, Morin PJ, Polyak K, Laken S, Vogelstein B, Kinzler KW: CDX2 is mutated in a colorectal cancer with normal APC/ beta-catenin signaling.C 87 Oncogene 1999, 18:5010014. 25. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990, 249:91215. 26. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE: The Fbw7 tumor suppressor regulates glycogen synthase kinase three phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004, 101:9085090. 27. Roepke M, Diestel A, Bajbouj K, Walluscheck D, Schonfeld P, Roessner A, Schneider-Stock R, Gali-Muhtasib H: Lack of p53 augments thymoquinoneinduced apoptosis and caspase activation in human osteosarcoma cells. Cancer Biol Ther 2007, six:16069. 28. El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA: Thymoquinone induces apoptosis by means of activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells.PMID:23805407 Int J Cancer 2005, 117:40917. 29. Gali-Muhtasib H, Kuester D, Mawrin C, Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C, Schoenfeld P, Peters B, et al: Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res 2008, 68:5609618. 30. Li Y, Bharti A, Chen D, Gong J, Kufe D: Interaction of glycogen synthase kinase 3beta with all the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol Cell Biol 1998, 18:7216224. 31. Houghton PJ, Zarka R, HB Dl, Hoult JR: Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 1995, 61:336. 32. Burits M, Bucar F: Antioxidant activity of Nigella sativa necessary oil. Phytother Res 2000, 14:32328. 33. Reagan-Shaw S, Nihal M, Ahmad N: Dose translation from animal to human studies revisited. FASEB J 2008, 22:65961. 34. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, Randhawa MA: Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in sufferers with non-ulcer dyspepsia. Saudi J G.
